Literature DB >> 22271809

Drug-induced vasculitis: a clinical and pathological review.

M Radić1, D Martinović Kaliterna, J Radić.   

Abstract

Drug-induced vasculitis is an inflammation of blood vessels caused by the use of various pharmaceutical agents. Vasculitis causes changes in the walls of blood vessels, including thickening, weakening, narrowing and scarring. Inflammation can be short-term (acute) or long-term (chronic) and can be so severe that the tissues and organs supplied by the affected vessels do not get enough blood. The shortage of blood can result in organ and tissue damage, even death. Drug-induced vasculitis is the most common form of vasculitis. The differential diagnosis between drug-induced and idiopathic vasculitic conditions may be difficult in the individual patient. Withdrawal may be helpful to distinguish between these syndromes. Withdrawal of the offending agent alone is often sufficient to induce prompt resolution of clinical manifestations, obviating the need for immunosuppressive and anti-inflammatory drugs. Increasing understanding of the pathophysiological characteristics of all inflammatory vasculitides should lead to better diagnostic and therapeutic approaches to drug-induced vasculitis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22271809

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  34 in total

Review 1.  Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Min Chen; Ying Gao; Xiao-Hui Guo; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2012-06-05       Impact factor: 28.314

2.  Antineutrophil cytoplasmic antibody-associated crescentic glomerulonephritis with membranous nephropathy treated using thiamazole.

Authors:  Tomoko Kakita; Katsuyuki Nagatoya; Hiroki Takimoto; Hirohisa Matsuda; Tatsuhiko Mori; Ayako Kawaguchi; Toru Inoue
Journal:  CEN Case Rep       Date:  2013-03-12

3.  Staphylococcus Infection-Associated GN - Spectrum of IgA Staining and Prevalence of ANCA in a Single-Center Cohort.

Authors:  Anjali A Satoskar; Sarah Suleiman; Isabelle Ayoub; Jessica Hemminger; Samir Parikh; Sergey V Brodsky; Cherri Bott; Edward Calomeni; Gyongyi M Nadasdy; Brad Rovin; Lee Hebert; Tibor Nadasdy
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-07       Impact factor: 8.237

4.  A case of intravascular large B-cell lymphoma with renal involvement presenting with elevated serum ANCA titers.

Authors:  Rina Oba; Kentaro Koike; Masahiro Okabe; Kei Matsumoto; Nobuo Tsuboi; Takashi Yokoo
Journal:  CEN Case Rep       Date:  2020-08-09

5.  c-ANCA vasculitis after initiation of denosumab.

Authors:  Alexandra Sanchez; Matthew Lozier; Brian Cody Adkinson; Amro Ilaiwy
Journal:  BMJ Case Rep       Date:  2019-03-01

Review 6.  Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.

Authors:  Brian A Baldo; Nghia H Pham
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

Review 7.  Overview of vasculitis and vasculopathy in rheumatoid arthritis--something to think about.

Authors:  Mislav Radic; Dusanka Martinovic Kaliterna; Josipa Radic
Journal:  Clin Rheumatol       Date:  2013-05-07       Impact factor: 2.980

Review 8.  Cutaneous Drug Reactions in the Elderly.

Authors:  James W S Young; Neil H Shear
Journal:  Drugs Aging       Date:  2017-09       Impact factor: 4.271

9.  Hydralazine-induced anti-neutrophil cytoplasmic antibody-positive renal vasculitis presenting with a vasculitic syndrome, acute nephritis and a puzzling skin rash: a case report.

Authors:  Justin Keasberry; Jeremy Frazier; Nicole M Isbel; Carolyn L Van Eps; Kimberley Oliver; David W Mudge
Journal:  J Med Case Rep       Date:  2013-01-14

Review 10.  Drug-Induced Vasculitis: New Insights and a Changing Lineup of Suspects.

Authors:  Rafael G Grau
Journal:  Curr Rheumatol Rep       Date:  2015-12       Impact factor: 4.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.